Related Experiment Video
Updated: Feb 1, 2026
08:00
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
14.1K
Pulmonary hypertension associated with bone marrow transplantation
Hajime Nakaoka1, Yasushi Sakata1, Masaki Yamamoto2
1Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan.
Journal of Cardiology Cases
|December 15, 2018
Summary
Bone marrow transplantation (BMT) can lead to rare complications like pulmonary arterial hypertension (PAH). This case study shows an adult patient with PAH post-BMT who significantly improved with medical treatment.
Area of Science:
- Hematology
- Pulmonology
- Oncology
Background:
- Bone marrow transplantation (BMT) is a vital treatment for hematologic malignancies.
- Conditioning regimens for BMT involve high-dose chemotherapy and radiation, posing risks of serious complications.
- Pulmonary hypertension is a rare but severe complication following BMT, with poorly understood mechanisms.
Observation:
- A 35-year-old female with acute myeloid leukemia (AML) developed pulmonary hypertension post-BMT.
- The patient presented with severe dyspnea, a hallmark symptom of pulmonary hypertension.
- Diagnosis was confirmed as pulmonary arterial hypertension (PAH) directly related to BMT.
Findings:
- The patient's severe dyspnea markedly improved with oxygen therapy.
- Pharmacological treatment with warfarin and beraprost sodium was initiated.
- This represents the first reported adult case of BMT-associated PAH showing significant improvement with medical intervention.
Implications:
- Pulmonary arterial hypertension (PAH) should be considered a potential complication in patients undergoing BMT.
- Early recognition of clinical symptoms and physical findings suggestive of PAH is crucial.
- Effective medical management strategies can lead to improved outcomes for BMT-related PAH.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
1.1K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
1.1K
01:30Pulmonary Hypertension: Classification and Pathogenesis
644
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
644
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
601
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
601
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
467
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
467
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
508
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
508
01:16Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
619
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
619